̽»¨Ö±²¥

Researchers trying to turn off a gene that allows cancers to spread have made a surprising U-turn. By making the gene overactive and functional in the hearts of mice, they have triggered heart cell regeneration.

Professor Laura Itzhaki is a group leader in the Department of Pharmacology and a Fellow of Newnham College. Here, she tells us about forming her own spin-out company, pitching to investors and her research on the 'workhorses' of the cell. 

A team at the ̽»¨Ö±²¥ of Cambridge has shown how, in osteoarthritis patients, the viscous lubricant that ordinarily allows our joints to move smoothly triggers a pain response from nerve cells similar to that caused by chilli peppers.

With our Postgraduate Open Day fast approaching (3 Nov), we introduce five PhD students who are already making waves at Cambridge.

̽»¨Ö±²¥discovery of a brain circuit ‘shortcut’ could explain why some addicts unintentionally relapse, and suggests that a shift in focus for therapies might help those who want to stay off drugs.

Individuals addicted to cocaine may have difficulty in controlling their addiction because of a previously-unknown ‘back door’ into the brain, circumventing their self-control, suggests a new study led by the ̽»¨Ö±²¥ of Cambridge.

Graham Ladds, lecturer in pharmacology, discusses the controversy around a group of drugs used to treat Type 2 diabetes.

Scientists have found that some drugs from a group of anti-diabetic treatments may, in certain circumstances, act on glucagon receptors in the body, meaning that they could also potentially enable the release of sugar into the bloodstream.

°Õ³ó±ðÌýCambridge Animal Alphabet series celebrates Cambridge's connections with animals through literature, art, science and society. Here, N is for Naked Mole-Rats, which won't win any beauty contests, but can live for 30 years and may be able to help in the development of new therapies for chronic pain.

AstraZeneca and the ̽»¨Ö±²¥ of Cambridge today announced three new joint schemes to support more than 80 PhD scholarships and eight clinical lectureships over the next five years spanning translational science, basic and clinical research. Two of the schemes are co-funded by the NIHR Cambridge Biomedical Research Centre, a partnership between Cambridge ̽»¨Ö±²¥ Hospitals and ̽»¨Ö±²¥ of Cambridge.